2026 NPPES data Internal Medicine Physician NPI 1386607265 MD
Verify on CMS →

MARIA RESTREPO, MD

Internal Medicine Physician in WILTON, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 207 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
79.0781/100
▼ 4 pts below national avg 83.1 · [object Object]
Industry payments
$24.83
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARIA RESTREPO, MD reported a CMS MIPS final score of 79.0781/100 — below the 83.1 national average — and filed 3,915 Medicare Part D claims in 2023.

79.0781/100
MIPS score · -4 vs avg
4K
Part D claims, 2023
82%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARIA RESTREPO, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

79 30th percentile higher than 30% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARIA RESTREPO, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARIA RESTREPO, MD?

Near national average

NPI registry status

Active

Issued 04/10/2006

NPI 1386607265

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

3,915 44% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

MIPS final score

79.0781/100 4.021899999999988% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Connecticut

How Internal Medicine Physician compares to other specialties among Connecticut providers

Connecticut providers

Internal Medicine Physician share within Connecticut

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within Connecticut

Medicare quality performance — MIPS

MARIA RESTREPO, MD's 2023 MIPS final score plotted against the Internal Medicine Physician national average

Near national average
MIPS Final Score
79.0781/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Internal Medicine Physician) — 79.0781/100 vs national avg 83.1

0%100%National avg83%79.1%
MIPS final score (Internal Medicine Physician) — 79.0781/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARIA RESTREPO, MD appears in the CMS NPPES registry as a Internal Medicine Physician provider holding MD credentials at 372 DANBURY RD STE 197, WILTON, CT, 06897, with a listed phone of (203) 276-3366. NPI 1386607265 was issued on 04/10/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RESTREPO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,915 prescription claims written by this provider, covering 207 Medicare beneficiaries and totaling roughly $995K in drug spend, split 18% brand-name and 82% generic by claim count, with an opioid prescribing rate of 0.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 79.0781/100 for the 2023 performance year (Quality 73.195, Cost 57.8987), compared with the national average of 83.1.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

372 DANBURY RD STE 197
WILTON, CT 06897

Provider Details

NPI 1386607265
Specialty Internal Medicine Physician
Credentials MD
Gender Female
NPI Issued 04/10/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

79.0781
Final Score
Avg: 83.1
73.195
Quality
57.8987
Cost
99
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARIA RESTREPO, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

STAMFORD HEALTH MEDICAL GROUP INC
WILTON, CT

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARIA RESTREPO, MD. Source: openpaymentsdata.cms.gov.

Total received

$25

Largest payer

UCB, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MARIA RESTREPO, MD — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 3,915 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,915
Total Claims
$995K
Total Drug Cost
207
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
9,928
Total Day Supply
292,960
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$895K
Generic Drug Cost
$96K
Opioid Claims
22 (0.6% rate)
Antibiotic Claims
43

Patient Demographics

Average Patient Age
74.7 years
Avg HCC Risk Score
1.15
Gender Split
66% female / 34% male
Age Distribution
<65: 11, 65-74: 93, 75-84: 77, 85+: 26

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARIA RESTREPO, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Rosuvastatin Calcium
455
Levothyroxine Sodium
169
Pantoprazole Sodium
158
Amlodipine Besylate
148
Famotidine
128
Metformin Hcl Er
Metformin Hcl
128
Losartan Potassium
116
Ozempic
Semaglutide
116
Atorvastatin Calcium
105
Metoprolol Succinate
79

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How MARIA RESTREPO, MD fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

MARIA RESTREPO, MD's 3,915 claims are above the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as RESTREPO.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARIA RESTREPO, MD's specialty?
MARIA RESTREPO, MD specializes in Internal Medicine Physician and practices in WILTON, Connecticut. Credentials: MD.
How much does MARIA RESTREPO, MD prescribe under Medicare Part D?
In 2023, MARIA RESTREPO, MD wrote 3,915 Medicare Part D claims totaling $995K in drug costs for 207 beneficiaries.
What is MARIA RESTREPO, MD's Medicare quality score?
MARIA RESTREPO, MD has a CMS MIPS Final Score of 79.0781/100 (Quality: 73.195, Cost: 57.8987). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARIA RESTREPO, MD located?
MARIA RESTREPO, MD is located at 372 DANBURY RD STE 197, WILTON, CT, 06897. Phone: (203) 276-3366.
What is MARIA RESTREPO, MD's NPI number?
MARIA RESTREPO, MD's National Provider Identifier (NPI) is 1386607265, issued on 04/10/2006.
Does MARIA RESTREPO, MD prescribe more brand-name or generic drugs?
MARIA RESTREPO, MD's prescribing is 18% brand-name and 82% generic drugs by claim count, with $895K in brand drug costs.
Does MARIA RESTREPO, MD prescribe opioids?
Yes, MARIA RESTREPO, MD had 22 opioid claims in 2023 with an opioid prescribing rate of 0.6%.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does MARIA RESTREPO, MD prescribe most often?
Based on 2023 Medicare Part D data, MARIA RESTREPO, MD's most frequently prescribed drugs include Rosuvastatin Calcium, Levothyroxine Sodium, Pantoprazole Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARIA RESTREPO, MD accept Medicare?
MARIA RESTREPO, MD appears in CMS Medicare data with 3,915 Part D claims and 207 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARIA RESTREPO, MD's credentials?
MARIA RESTREPO, MD's NPI is 1386607265 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology